156 related articles for article (PubMed ID: 25752197)
1. Telomere fusion threshold identifies a poor prognostic subset of breast cancer patients.
Simpson K; Jones RE; Grimstead JW; Hills R; Pepper C; Baird DM
Mol Oncol; 2015 Jun; 9(6):1186-93. PubMed ID: 25752197
[TBL] [Abstract][Full Text] [Related]
2. Telomere length alterations unique to invasive lobular carcinoma.
Heaphy CM; Asch-Kendrick R; Argani P; Meeker AK; Cimino-Mathews A
Hum Pathol; 2015 Aug; 46(8):1197-203. PubMed ID: 26092192
[TBL] [Abstract][Full Text] [Related]
3. Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index.
Kurozumi S; Matsumoto H; Hayashi Y; Tozuka K; Inoue K; Horiguchi J; Takeyoshi I; Oyama T; Kurosumi M
BMC Cancer; 2017 May; 17(1):354. PubMed ID: 28532429
[TBL] [Abstract][Full Text] [Related]
4. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M;
Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648
[TBL] [Abstract][Full Text] [Related]
5. Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease.
Lin TT; Norris K; Heppel NH; Pratt G; Allan JM; Allsup DJ; Bailey J; Cawkwell L; Hills R; Grimstead JW; Jones RE; Britt-Compton B; Fegan C; Baird DM; Pepper C
Br J Haematol; 2014 Oct; 167(2):214-23. PubMed ID: 24990087
[TBL] [Abstract][Full Text] [Related]
6. Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancer.
Pinto AE; Pereira T; Silva GL; André S
Breast; 2015 Aug; 24(4):449-55. PubMed ID: 25920680
[TBL] [Abstract][Full Text] [Related]
7. Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer.
Masarwah A; Auvinen P; Sudah M; Dabravolskaite V; Arponen O; Sutela A; Oikari S; Kosma VM; Vanninen R
BMC Cancer; 2016 Nov; 16(1):833. PubMed ID: 27806715
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 is a highly significant prognostic marker of hormone-receptor-positive, human epidermal growth factor receptor-2-negative breast cancer.
Seong MK; Lee JY; Byeon J; Sohn YJ; Seol H; Lee JK; Kim EK; Kim HA; Noh WC
Breast Cancer Res Treat; 2015 Feb; 150(1):141-8. PubMed ID: 25682076
[TBL] [Abstract][Full Text] [Related]
9. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
10. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
11. Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer.
Eggemann H; Ignatov T; Burger E; Kantelhardt EJ; Fettke F; Thomssen C; Costa SD; Ignatov A
Endocr Relat Cancer; 2015 Oct; 22(5):725-33. PubMed ID: 26187126
[TBL] [Abstract][Full Text] [Related]
12. Evolutionary hypothesis of telomere length in primary breast cancer and brain tumour patients: a tracer for genomic-tumour heterogeneity and instability.
Mehdipour P; Kheirollahi M; Mehrazin M; Kamalian N; Atri M
Cell Biol Int; 2011 Sep; 35(9):915-25. PubMed ID: 21385157
[TBL] [Abstract][Full Text] [Related]
13. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma.
Vo TN; Mekata E; Umeda T; Abe H; Kawai Y; Mori T; Kubota Y; Shiomi H; Naka S; Shimizu T; Murata S; Yamamoto H; Ishida M; Tani T
Breast Cancer; 2015 Mar; 22(2):117-28. PubMed ID: 23575921
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
16. Comparison of telomere length and insulin-like growth factor-binding protein 7 promoter methylation between breast cancer tissues and adjacent normal tissues in Turkish women.
Kaya Z; Akkiprik M; Karabulut S; Peker I; Gullu Amuran G; Ozmen T; Gulluoglu BM; Kaya H; Ozer A
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27775181
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Relative Telomere Length is Associated With hTERT Gene Expression in the Tissue of Patients With Breast Cancer.
Thriveni K; Raju A; Kumar RV; Krishnamurthy S; Chaluvarayaswamy R
Clin Breast Cancer; 2019 Feb; 19(1):27-34. PubMed ID: 30217473
[TBL] [Abstract][Full Text] [Related]
18. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.
Lanigan F; McKiernan E; Brennan DJ; Hegarty S; Millikan RC; McBryan J; Jirstrom K; Landberg G; Martin F; Duffy MJ; Gallagher WM
Int J Cancer; 2009 May; 124(9):2088-97. PubMed ID: 19142967
[TBL] [Abstract][Full Text] [Related]
19. Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control study.
Pavanello S; Varesco L; Gismondi V; Bruzzi P; Bolognesi C
PLoS One; 2018; 13(5):e0197522. PubMed ID: 29782524
[TBL] [Abstract][Full Text] [Related]
20. Association between prediagnostic leukocyte telomere length and breast cancer risk: the Singapore Chinese Health Study.
Samavat H; Xun X; Jin A; Wang R; Koh WP; Yuan JM
Breast Cancer Res; 2019 Apr; 21(1):50. PubMed ID: 30995937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
